Clinical Trial News and Research

RSS

UK’s COVID-19 vaccine shows similar safety and immunogenicity results in healthy older adults

The UK's vaccine against SARS-CoV-2 shows similar safety and immunogenicity results in healthy older adults (aged 56 years and over) to those seen in adults aged 18-55 years.

19 Nov 2020

Study: Pod e-cigarettes are less damaging to health than traditional cigarettes

Cigarette smoking causes more than 480,000 deaths each year in the United States, according to federal government data -- and some smokers find it nearly impossible to quit. Many of these smokers use regular, or combustible, cigarettes.

18 Nov 2020

Immunotherapies effective against lung cancer, melanoma may also work against rare skin tumor

Cutaneous angiosarcoma is a rare, highly aggressive skin tumor found primarily on the scalps of older White people, but based on new research from the University of North Carolina School of Medicine and the Lineberger Comprehensive Cancer Center, immunotherapies effective against lung cancer and melanoma may also work against this cancer.

18 Nov 2020

Government-funded scientists laid the groundwork for billion-dollar vaccines

When he started researching a troublesome childhood infection nearly four decades ago, virologist Dr. Barney Graham, then at Vanderbilt University, had no inkling his federally funded work might be key to deliverance from a global pandemic.

18 Nov 2020

Certain regions in the retina are more affected by Alzheimer's disease, shows study

A study led by the Cedars-Sinai Department of Neurosurgery has identified certain regions in the retina - the lining found in the back of the eye - that are more affected by Alzheimer's disease than other areas.

18 Nov 2020

LOX plays a number of key roles in promoting skin and organ fibrosis in scleroderma

A team of researchers at the Medical University of South Carolina (MUSC) has found that the molecule lysyl oxidase (LOX) plays a number of important roles in promoting skin and organ fibrosis in scleroderma, a connective tissue disorder.

17 Nov 2020

Study shows favorable impact of medication on cardiac structure and function

For the first time, medication has impacted heart muscle thickness and function for patients with the most common inherited heart condition, rather than simply addressing their symptoms.

17 Nov 2020

Vitamin D and omega-3 fatty acids do not prevent atrial fibrillation, shows study

New research presented today at the American Heart Association Scientific Sessions suggests neither vitamin D nor the omega-3 fatty acids found in fish oil prevent the development of atrial fibrillation, a potentially serious heart rhythm disturbance.

17 Nov 2020

Clinical trials show SGLT2 inhibitor may benefit patients with type 2 diabetes

Less than a decade ago, the Food and Drug Administration approved drugs for treating type 2 diabetes in an entirely new way.

16 Nov 2020

Revolutionary 3D color wrist scanner to be tested in international trial

A revolutionary compact 3D colour wrist scanner invented by a University of Otago, Christchurch professor will soon be tested in a large scale international clinical trial. This development follows a promising pilot study with New Zealand orthopaedic patients.

16 Nov 2020

Lower choline in pregnant Black American women linked to higher levels of stress hormone

Researchers at the University of Colorado Anschutz Medical Campus have found that many pregnant Black Americans have low levels of choline, an essential nutrient that aids in prenatal brain development. Stress caused by institutional racism may play a role.

16 Nov 2020

First-ever phase 3 advanced anal cancer trial opens for patient enrollment

The first randomized phase 3 clinical trial ever to be conducted in patients with advanced cancer of the anal canal is now open and enrolling patients.

16 Nov 2020

Patients' own stem cells can be used to grow new bones, study shows

A new, groundbreaking study from the University of Bergen shows that a patients' own stem cells can be used to grow new bone.

16 Nov 2020

Additional imaging tests can detect cause of heart attack in women with no major artery blockage

Diagnostic imaging techniques were able to find the underlying cause of heart attack in many women who had no major artery blockage, according to late- breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Moderna's COVID-19 vaccine nearly 95% effective

US company Moderna have just released their early phase 3 clinical trial results for their COVID-19 vaccine which is nearly 95% effective.

16 Nov 2020

People taking placebo pills and statins experienced similar side effects, shows study

People taking dummy pills and statins experienced similar side effects in a new study.

15 Nov 2020

Diabetes drug can ameliorate lives of chronic heart failure patients

Empagliflozin, a recently developed diabetes drug, can effectively treat and reverse heart failure in both diabetic and non-diabetic patients, according to researchers at the Icahn School of Medicine at Mount Sinai.

15 Nov 2020

Immunotherapy combination shrinks rare angiosarcoma tumors in 25% of patients

Researchers from SWOG Cancer Research Network, a cancer clinical trials group funded by the National Cancer Institute's Division of Cancer Diagnosis and Treatment, part of the National Institutes of Health, have shown that the immunotherapy combination of ipilimumab and nivolumab shrinks rare angiosarcoma tumors in 25 percent of all patients, with some having an even stronger response to the drug combination.

15 Nov 2020

Polypill plus aspirin and polypill alone reduced cardiovascular disease risk

A single, daily pill combining blood pressure and cholesterol medications, along with the addition of a daily dose of aspirin, reduced cardiovascular disease events in people at risk for heart disease, according to late-breaking research presented today in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2020.

15 Nov 2020

WHO approves first ever vaccine for emergency use to address polio

WHO today listed the nOPV2 vaccine (Bio Farma, Indonesia) for emergency use to address the rising cases of a vaccine-derived polio strain in a number of African and East Mediterranean countries.

15 Nov 2020

Clinical Trial News and Research

UK’s COVID-19 vaccine shows similar safety and immunogenicity results in healthy older adults

Study: Pod e-cigarettes are less damaging to health than traditional cigarettes

Immunotherapies effective against lung cancer, melanoma may also work against rare skin tumor

Government-funded scientists laid the groundwork for billion-dollar vaccines

Certain regions in the retina are more affected by Alzheimer's disease, shows study

LOX plays a number of key roles in promoting skin and organ fibrosis in scleroderma

Study shows favorable impact of medication on cardiac structure and function

Vitamin D and omega-3 fatty acids do not prevent atrial fibrillation, shows study

Clinical trials show SGLT2 inhibitor may benefit patients with type 2 diabetes

Revolutionary 3D color wrist scanner to be tested in international trial

Lower choline in pregnant Black American women linked to higher levels of stress hormone

First-ever phase 3 advanced anal cancer trial opens for patient enrollment

Patients' own stem cells can be used to grow new bones, study shows

Additional imaging tests can detect cause of heart attack in women with no major artery blockage

Moderna's COVID-19 vaccine nearly 95% effective

People taking placebo pills and statins experienced similar side effects, shows study

Diabetes drug can ameliorate lives of chronic heart failure patients

Immunotherapy combination shrinks rare angiosarcoma tumors in 25% of patients

Polypill plus aspirin and polypill alone reduced cardiovascular disease risk

WHO approves first ever vaccine for emergency use to address polio

eBook: Using iPSCs models for human disease research and drug discovery eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer